Legend Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Legend Financial Advisors's ARKG Position: Q1 2025 in Review
Legend Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 281 shares — an estimated $6.62K sold.
Legend Financial Advisors first reported a position in ARKG in Q1 2019 and held it in 14 quarters. The position peaked at $19M in Q4 2020. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.
- Legend Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
- Legend Financial Advisors sold 281 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $6.62K.
- Legend Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2019 and held it in 14 quarters.
- Legend Financial Advisors's ARK Genomic Revolution ETF position peaked at $19M in Q4 2020.
- 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.
Based on Legend Financial Advisors's 13F filing for Q1 2025, filed 14 May 2025.